Form 4 Tracker
ARROWHEAD PHARMACEUTICALS, INC.
ARWR

3 insider filings · Latest: Apr 23, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jan 6, 2025Jan 6 10:48 PMMyszkowski Kenneth Allen
Proposed Sale
5,817$19.82$115.3K

View →

Jan 6, 2025Jan 6 10:40 PMMyszkowski Kenneth Allen
Proposed Sale
9,255$19.82$183.5K

View →

Jan 6, 2025Jan 6 10:33 PMMyszkowski Kenneth Allen
Proposed Sale
6,287$19.80$124.5K

View →

Jan 6, 2025Jan 6 10:26 PMMyszkowski Kenneth Allen
Proposed Sale
5,817$19.82$115.3K

View →

Jan 6, 2025Jan 6 10:19 PMHamilton James C
Proposed Sale
32,729$19.82$648.7K

View →

Jan 6, 2025Jan 6 10:05 PMO'Brien Patrick
Proposed Sale
29,184$19.82$578.5K

View →

Jan 2, 2025Jan 2 9:16 PMAnzalone Christopher Richard
Proposed Sale
11,520$19.04$219.4K

View →

Dec 27, 2024Dec 27 9:23 PMOLUKOTUN ADEOYE Y
Proposed Sale
2,850$19.99$57.0K

View →

Dec 23, 2024Dec 23 9:16 PMAnzalone Christopher Richard
Proposed Sale
12,563$19.59$246.1K

View →

Dec 18, 2024Dec 18 9:41 PMAnzalone Christopher Richard
Proposed Sale
26,712$21.24$567.4K

View →

Dec 17, 2024Dec 17 10:06 PMGIVEN DOUGLAS B
Proposed Sale
547$21.98$12.0K

View →

Dec 17, 2024Dec 17 9:53 PMWaddill William D.
Proposed Sale
3,747$22.03$82.6K

View →

Dec 16, 2024Dec 16 9:44 PMWaddill William D.
Proposed Sale
3,748$21.89$82.1K

View →

Dec 16, 2024Dec 16 9:30 PMVakiener Victoria
Proposed Sale
8,994$21.91$197.1K

View →

Dec 16, 2024Dec 16 9:15 PMGIVEN DOUGLAS B
Proposed Sale
5,000$21.89$109.5K

View →

← Previous

Page 3 of 3

Stock Options & Derivatives

No transactions found.